Drug Patents owned by Acer
1. List of Olpruva drug patents
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US11202767 | ACER | Methods of treating urea cycle disorders and maple syrup urine disease |
Oct, 2036
(13 years from now) | |
| US11433041 | ACER | Palatable compositions including sodium phenylbutyrate and uses thereof |
Oct, 2036
(13 years from now) | |
| US11154521 | ACER | Palatable compositions including sodium phenylbutyrate and uses thereof |
Oct, 2036
(13 years from now) | |
Do you want to check out OLPRUVA patents from before 2022?
Drugs and Companies using SODIUM PHENYLBUTYRATE ingredient
Market Authorisation Date: 22 December, 2022
Treatment: Treatment of a urea cycle disorder involving deficiencies of carbamylphosphate synthetase, ornithine transcarbamylase, or argininosuccinic acid synthetase
Dosage: FOR SUSPENSION;ORAL
More Information on Dosage
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic